HCPLive Network
Latest Oncology Headlines
By Anita T. Shaffer
An improved assay for assessing MRD status in patients with multiple myeloma is contributing to the momentum for using MRD as a surrogate endpoint for survival in clinical trials and as a tool with the potential to help guide therapy choices.
The patient-clinician relationship has a small but significant effect on health care outcomes, according to a study published online April 9 in PLOS ONE.
The key issues for future physicians are discussed in an article published by the American Medical Association.
By Silas Inman
Talimogene laherparepvec significantly improved durable response rates but failed to extend overall survival in patients with advanced melanoma.
Yoga and meditation are popular on the West Coast, Midwesterners often turn to chiropractors or osteopathic doctors, and nearly one in every five Americans use herbal supplements. These are among the findings of a new federal government report published in the US Centers for Disease Control and Prevention's April edition of the National Center for Health Statistics Data Brief.
By Silas Inman
The FDA has approved ofatumumab plus chlorambucil for previously untreated patients with chronic lymphocytic leukemia who are considered inappropriate for treatment with fludarabine therapy.
By Tony Berberabe, MPH
Epizyme, a Cambridge, Massachusetts-based biotech, opted for independence, with a successful IPO in 2013.
Physicians who use Windows XP in their practices may be affected by Microsoft's recent discontinuation of support for the program, according to an article published April 8 in Medical Economics.
Six percent of patients with colorectal cancer have interval cancers, which develop within six to 60 months of colonoscopy, according to a study published in the April issue of Gastroenterology.
By By Lary A. Robinson, MD
Every patient with a pancoast tumor of the lung should be evaluated by a Pancoast-experienced thoracic surgeon (and neurosurgeon) before ruling out surgery, and before starting induction therapy.
Many Americans are paying less for prescription drugs, but some are having to deal with sharp rises in the cost of specialty medicines for rare or serious diseases, according to a new report.
By Anna Azvolinsky, PhD
Lymphoma expert Andre Goy, MD, provides insight into the rapidly changing treatment landscape for patients with mantle cell lymphoma.
The use of neoadjuvant and adjuvant chemotherapy for the treatment of muscle-invasive bladder cancer is associated with a survival benefit in the general population, according to research published online April 14 in Cancer.
By Andrew J. Roth
Patients with localized prostate cancer at intermediate or high risk for progression experience better outcomes when 6 months of androgen deprivation therapy is added to standard radiotherapy.
Cytomegalovirus may contribute to anemia in patients with chronic kidney disease, according to a study published online April 10 in the Journal of the American Society of Nephrology.
With the resignation of US Health and Human Services Secretary Kathleen Sebelius on Friday, the Affordable Care Act will get a fresh face. But turning around public perception of the controversial health care reform law in a politically charged mid-term election year poses an enormous challenge for the department's next leader, policy experts said.
The future of privately owed oncology practices in the nation’s cancer care system is growing increasingly fragile amid mounting financial pressures, even as more new patients are seeking help.
High intake of saturated fats is associated with increased risk of certain subtypes of breast cancer, according to research published online April 9 in the Journal of the National Cancer Institute.
By Silas Inman
A novel 100-locus DNA signature obtained from pretreatment biopsies accurately classified 75% of patients with untreated prostate cancer as low- or high-risk.
By Silas Inman
The recent approval of pertuzumab as part of a combination neoadjuvant treatment for patients with early-stage breast cancer has paved the way for wider use of the regimen in preoperative settings.
Physician's Money Digest
Reverse mortgages have been advertised more and more during the recent run-up in home prices, but not every senior is a good candidate for one.
For most Americans, summer is vacation time; however, little else can ruin a trip like getting sick. Often, this is as small as a runny nose and a cough, but sometimes the illnesses travelers pick up can be far more serious.
$AD300x250BB$